AI assistant
Sending…
StageZero Life Sciences Ltd. — Regulatory Filings 2023
Apr 1, 2023
44586_rns_2023-03-31_ef19980e-c7fd-4628-aaac-b76a187891de.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
| theAIF(together,the"annualfilings")of StageZero Life Sciences Ltd.(the"issuer")for thefinancialyear endedDecember 31, 2022. | |
|---|---|
| 2. | **No misrepresentations:**Basedon myknowledge,havingexercised reasonable diligence,the |
| annualfilingsdo notcontainanyuntruestatementof amaterial factoromittostateamaterial | |
| factrequiredto bestatedorthatisnecessarytomakeastatementnotmisleadinginlightof the | |
| circumstances under whichit wasmade,for theperiodcoveredby theannualfilings. | |
| 3. | **Fair presentation:**Basedon myknowledge, havingexercisedreasonablediligence,theannual |
| financialstatements togetherwiththeotherfinancialinformationincludedin theannualfilings | |
| fairlypresentin allmaterialrespectsthefinancial condition, financial performanceandcash | |
| flowsof theissuer,as of thedateof and for theperiods presentedin theannualfilings. | |
| 4. | **Responsibility:**Theissuer's othercertifyingofficer(s)and I areresponsibleforestablishingand |
| maintainingdisclosure controlsandprocedures (DC&P)andinternalcontrol overfinancial | |
| reporting(ICFR),asthose termsaredefinedinNationalInstrument52-109_Certification of_ | |
| _Disclosure in Issuers ' Annual and Interim Filings,_for theissuer. | |
| 5. | **Design:**Subjectto thelimitations,ifany, describedinparagraphs5.2 and5.3,theissuer's other |
| certifyingofficer(s)and Ihave,as at thefinancialyearend | |
| (a)designed DC&P,orcausedit to bedesigned underoursupervision,toprovide reasonable | |
| assurance that | |
| (i)materialinformationrelatingto theissuerismade knownto us byothers, | |
| particularly duringtheperiodinwhichtheannual filingsarebeing prepared;and | |
| (ii)information requiredto bedisclosedby theissuerin itsannualfilings,interim | |
| filingsorother reportsfiledorsubmittedby itunder securitieslegislationis | |
| recorded,processed,summarizedandreported withinthetime periods specified | |
| insecuritieslegislation;and | |
| (b)designed ICFR,orcausedit to bedesigned underoursupervision,toprovide reasonable | |
| assurance regardingthereliabilityoffinancialreportingand thepreparationoffinancial | |
| statementsforexternal purposesinaccordance withtheissuer's GAAP. | |
| 5.1 | **Control framework:**Thecontrol frameworktheissuer's othercertifyingofficer(s)and Iusedto |
| designtheissuer's ICFRisInternalControl-Integrated Framework issuedby theCommitteeof | |
| SponsoringOrganizationsof theTreadway Commission (COSO)(2013). |
More from StageZero Life Sciences Ltd.
Capital/Financing Update
2026
Jan 27
Capital/Financing Update
2026
Jan 21
Regulatory Filings
2026
Jan 19
Regulatory Filings
2025
Aug 15
Delisting Announcement
2025
Jul 28
Regulatory Filings
2025
May 13
Capital/Financing Update
2025
May 7
Audit Report / Information
2025
Apr 23
Regulatory Filings
2024
Dec 16
Regulatory Filings
2024
Dec 16